Janssen Research and Development

Research and development organisation of the pharmaceutical business of Johnson & Johnson, known as Janssen Research and Development until the group renamed the business Johnson & Johnson Innovative Medicine in 2023, with sites in Belgium, the Netherlands, the United States, Spain and elsewhere. Discovers and develops medicines and vaccines in oncology, immunology, neuroscience, infectious diseases, pulmonary hypertension and cardiovascular and metabolic disease, running discovery chemistry and biology, non-clinical safety and toxicology, translational science and clinical development.